Résumé
En France, le cancer du sein est le plus fréquent chez la femme avec une incidence qui ne cesse d’augmenter depuis les deux dernières décennies avec cependant une mortalité à la baisse [1]. Le dépistage systématique a permis un diagnostic d’un nombre plus élevé de cancers du sein de stade précoce et potentiellement curables.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Références
Belot A, Grosclaude P, Bossard N et al. (2008) Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 56: 159–175
Perou CM, Sørlie T, Eisen MB et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747–752
Sørlie T, Perou CM, Tibshirani R et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869–10874
van’ t Veer LJ, Dai H, van de Vijver MJ et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536
Paik S, Shak S, Tang G et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817–2826
Wang Y, Klijn JG, Zhang Y et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671–679
Chang HY, Nuyten DS, Sneddon JB et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102: 3738–3743
Liu R, Wang X, Chen GY et al. (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356: 217–226
van Beers EH, Nederlof PM (2006) Array-CGH and breast cancer. Breast Cancer Res 8: 210
Khodarev NN, Beckett M, Labay E et al. (2004) STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA 101: 1714–1719
Clarke M, Collins R, Darby S et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087–2106
Bartelink H, Horiot JC, Poortmans P et al. (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345: 1378–1387
Dilhuydy JM, Bussieres E, Romestaing P (2001) Radiotherapy of the breast and chest wall: treatment volume. Cancer Radiother 5: 550–559
Fernando IN, Ford HT, Powles TJ et al. (1996) Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 8: 226–233
Karlsson P, Cole BF, Price KN et al. (2007) The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol 25: 2019–2026.
Vicini FA, Kestin L, Huang R et al. (2003) Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer 97: 910–919
Elkhuizen PH, van de Vijver MJ, Hermans J et al. (1998) Local recurrence after breastconserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40: 859–867
Arriagada R, Lê MG, Contesso G et al. (2002) Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 13: 1404–413
Arriagada R, Le MG, Guinebretiere JM et al. (2003) Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14: 1617–1622
Huston TL, Simmons RM (2005) Locally recurrent breast cancer after conservation therapy. Am J Surg 189: 229–235
Clarke DH, Lê MG, Sarrazin D et al. (1985) Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11: 137–145
Fourquet A, Campana F, Zafrani B et al. (1989) Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 17: 719–725
Fisher B, Anderson S, Fisher ER et al. (1991) Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338: 327–331
Locker AP, Ellis IO, Morgan DA et al. (1989) Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 76: 890–894
Dragun, A.E, Pan J, Rai SN, Kruse B, Jain D (2011) Locoregional Recurrence in Patients With Triple-Negative Breast Cancer: Preliminary Results of a Single Institution Study. Am J Clin Oncol (in press)
Wang SL, Li YX, Song YW et al. (2011) Triple-Negative or HER2-Positive Status Predicts Higher Rates of Locoregional Recurrence in Node-Positive Breast Cancer Patients After Mastectomy. Int J Radiat Oncol Biol Phys (in press)
Solin LJ, Hwang WT, Vapiwala N (2009) Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma. Clin Breast Cancer 9: 96–100
Parikh RR, Yang Q, Higgins SA, Haffty BG (2008) Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys 70: 35–42
Freedman GM, Anderson PR, Tianyu L, Nicolaou N (2009) Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer 115: 946–951
Bourgier C et al. (2006) Molecular subclassification and risk of locoregional relapses in early breast cancer patients. San Antonio Breast Cancer Symposium Annual Meeting. Personal Communication, 2006. Abstract 6028.
Truong PT, Lesperance M, Sanghani M et al. (2008) Independent Validation of IBTR ! A Computer-based Tool to Predict Ipsilateral Breast Recurrence in Women with Invasive Breast Cancer Treated with Breast Conserving Surgery. Int J Radiat Oncol Biol Phys 72: #203
Sanghani M, Truong PT, Raad RA et al. (2008) Validation of a Web-based Predictive Nomogram for Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy. Int J Radiat Oncol Biol Phys 72: S91
Nuyten DS, Kreike B, Hart AA et al. (2006) Predicting a local recurrence after breastconserving therapy by gene expression profiling. Breast Cancer Res 8: R62
Weichselbaum RR, Ishwaran H, Yoon T et al. (2008) An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci USA 105: 18490–18495
Kreike B, Halfwerk H, Armstrong N et al. (2009) Local recurrence after breastconserving therapy in relation to gene expression patterns in a large series of patients. Clin Cancer Res 1512: 4181–4190
Nguyen PL, Taghian AG, Katz MS et al. (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26: 2373–2378
Liang K, Lu Y, Jin W et al. (2003) Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther 2: 1113–1120
Pietras RJ, Poen JC, Gallardo D et al. (1999) Monoclonal antibody to HER-2/ neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res 59: 1347–1355
Sambade MJ, Kimple RJ, Camp JT et al. (2010) Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts. Int J Radiat Oncol Biol Phys 77: 575–581
Sambade MJ, Camp JT, Kimple RJ et al. (2009) Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. Radiother Oncol 93: 639–644
Horton JK, Halle J, Ferraro M et al. (2010) Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer with Trastuzumab: A Phase II Trial. Int J Radiat Oncol Biol Phys 76: 998–1004
Collette S, Collette L, Budiharto T et al. (2008) Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 ‘boost versus no boost’. Eur J Cancer 44: 2587–2599
Ozsahin M, Ozsahin H, Shi Y et al. (1997) Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys 38: 429–440
Crompton NE, Shi YQ, Emery GC et al. (2001) Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 49: 547–554
Slonina D, Gasinska A (1997) Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J Radiat Biol 72: 693–701
Azria D, Ozsahin M, Kramar A et al. (2008) Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 14: 6284–6288
Ozsahin M, Crompton NEA, Gourgou S et al. (2005) 2005CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 11: 7426–7433
Rights and permissions
Copyright information
© 2012 Springer-Verlag France, Paris
About this paper
Cite this paper
Bourgier, C. (2012). Outils génomiques du choix thérapeutique des cancers du sein. Quelles perspectives à court et moyen terme sur le traitement locorégional. Opinion du radiothérapeute?. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/978-2-8178-0245-9_27
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0245-9_27
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0244-2
Online ISBN: 978-2-8178-0245-9